Angiotensin-converting enzyme inhibitor for post-transcatheter aortic valve implantation patients: study protocol for a multicenter randomized, open-label blinded endpoint control trial

Peer Review reports

Original Submission
3 May 2021	Submitted	Original manuscript
13 May 2021	Reviewed	Reviewer Report - Muslim Syed
24 May 2021	Reviewed	Reviewer Report - Sachin Goel
17 Jun 2021	Author responded	Author comments - Yanbiao Liao
Resubmission - Version 2
17 Jun 2021	Submitted	Manuscript version 2
17 Jun 2021	Reviewed	Reviewer Report - Muslim Syed
27 Jun 2021	Reviewed	Reviewer Report - Sachin Goel
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
30 Jun 2021	Editorially accepted
18 Jul 2021	Article published	10.1186/s13063-021-05411-5

Back to article page